{"id":46,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=46"},"modified":"2026-05-16T14:06:28","modified_gmt":"2026-05-16T12:06:28","slug":"retatrutide","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/nl\/shop\/retatrutide\/","title":{"rendered":"Retatrutide"},"content":{"rendered":"

Retatrutide - Multi-Receptorpeptide voor metabolisme- en gewichtsbeheersing<\/strong><\/p>\n

Samenstelling: <\/strong>Retatrutide (gevriesdroogd peptidepoeder)
Categorie:<\/strong> Peptide
Vorm:<\/strong> Flacon met gevriesdroogd poeder
Administratie:<\/strong> Subcutane injectie na reconstitutie met bacteriostatisch water<\/p>\n

\n

Wat is Retatrutide?<\/h3>\n

Retatrutide is een geavanceerde, langwerkende drievoudige agonistische peptide<\/strong> die tegelijkertijd de GLP-1 (Glucagon-Like Peptide-1)<\/strong>, GIP (glucoseafhankelijk insulinotroop polypeptide)<\/strong>, en Glucagonreceptoren<\/strong>.
Het behoort tot een nieuwe generatie peptiden voor metabolisch onderzoek<\/strong> ontworpen om het energieverbruik verhogen<\/strong>, eetlust reguleren<\/strong>, en het glucose- en vetmetabolisme verbeteren<\/strong>.<\/p>\n

Door de gelijktijdige activering van meerdere metabolische routes heeft Retatrutide een opmerkelijk potentieel laten zien in preklinische en klinische onderzoeken<\/strong> onderzoek naar obesitas, insulineresistentie,<\/strong> en stofwisselingsstoornissen<\/strong>.<\/p>\n

\u27a1\ufe0f Ideaal voor energiebalans, gewichtsregeling,<\/strong> en op peptiden gebaseerde metabolische modulatie.<\/strong><\/p>\n

\n

Belangrijkste onderzoeksresultaten<\/h3>\n

Drievoudige Receptor Activatie:<\/strong> Gelijktijdige stimulatie van GLP-1, GIP,<\/strong> en Glucagonreceptoren<\/strong> voor verbeterde metabolische effici\u00ebntie.<\/p>\n

Eetlust- en energieregulatie:<\/strong> Be\u00efnvloedt centrale mechanismen van controle over eetlust<\/strong> en bevordert calorie-uitgaven<\/strong>.<\/p>\n

Glucose- en lipidenmetabolisme:<\/strong> Ondersteunt verbeterde insulinegevoeligheid, glucosehomeostase,<\/strong> en vetoxidatie<\/strong>.<\/p>\n

Lichaamssamenstelling:<\/strong> Bestudeerd voor zijn potentieel om lichaamsvet verminderen<\/strong> terwijl behoud van vetvrije massa<\/strong>.<\/p>\n

\n

Dosering en toepassing<\/h3>\n

Reconstitueer met bacteriostatisch water<\/strong> voor gebruik.<\/p>\n

Typisch onderzoeksbereik: 0,25-1,0 mg per toepassing<\/strong>, subcutaan (afhankelijk van de onderzoeksopzet).<\/p>\n

Frequentie: Variabel, vaak 1-2 keer per week<\/strong> in metabole studies op lange termijn.<\/p>\n

Bewaar de gereconstitueerde oplossing gekoeld<\/strong> en gebruik binnen 30 dagen<\/strong>.<\/p>\n

\n

Instructies voor opslag<\/h3>\n
    \n
  • \n

    Opslaan bij 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Beschermen tegen licht en vocht<\/strong><\/p>\n<\/li>\n

  • \n

    Niet invriezen<\/strong><\/p>\n<\/li>\n

  • \n

    Temperatuurschommelingen vermijden<\/p>\n<\/li>\n<\/ul>\n

    \n

    Waarom Retatrutide kiezen?<\/h3>\n

    Retatrutide is een van de meest geavanceerde multi-agonistische peptiden<\/strong> wordt momenteel onderzocht.
    Door zijn synergetische activering van GLP-1-, GIP- en Glucagon-receptoren<\/strong>, Het biedt unieke inzichten in de hormonale regulering van de energiebalans, vetstofwisseling en eetlustcontrole<\/strong>.<\/p>\n

    Retatrutide bestellen <\/strong>\u00a0en het potentieel ervan in de volgende generatie onderzoek naar stofwisseling en gewichtsbeheersing.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Retatrutide \u2013 Multi-Receptor Peptide for Metabolic & Weight Management Composition: Retatrutide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Retatrutide? Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and improve glucose and lipid metabolism. Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical studies investigating obesity, insulin resistance, and metabolic disorders. \u27a1\ufe0f Ideal for energy balance, weight regulation, and peptide-based metabolic modulation. Key Research Findings Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic efficiency. Appetite & Energy Regulation: Influences central mechanisms of appetite control and promotes caloric expenditure. Glucose & Lipid Metabolism: Supports improved insulin sensitivity, glucose homeostasis, and fat oxidation. Body Composition: Studied for its potential to reduce body fat while preserving lean mass. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously (depending on study design). Frequency: Variable, often 1\u20132 times per week in long-term metabolic studies. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Retatrutide? Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control. Order Retatrutide \u00a0and explore its potential in the next generation of metabolic and weight management research.<\/p>","protected":false},"featured_media":59,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":{"0":"post-46","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-all-products","7":"product_cat-glp-1andmultiagonist","8":"product_cat-metabolismandweightmanagement","9":"product_cat-peptidesandresearchdrugs","10":"entry","11":"has-media","13":"first","14":"instock","15":"sale","16":"purchasable","17":"product-type-variable"},"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/46","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/46\/revisions"}],"predecessor-version":[{"id":28952,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/46\/revisions\/28952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/media\/59"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/media?parent=46"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_brand?post=46"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_cat?post=46"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_tag?post=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}